MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.71773

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change.

Denkinger Marisa N, Brum Wagner S, Leuzy Antoine, Singh Alpana, Marques Taina M, Ghisays Valentina, Protas Hillary, Su Yi, Atri Ali, Beach Thomas G, Serrano Geidy E, Bhatt Kinal, Carlson Corey M, Hoffmann Katharine, Reiman Eric M, Ashton Nicholas J

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Plasma phosphorylated tau (p-tau), particularly p-tau217, is a highly specific biomarker of Alzheimer's disease (AD) pathology. However, plasma p-tau217 can be elevated in rare non-AD conditions. Brain-derived (BD) p-tau217 may reduce these off-target effects, but its performance against neuropathology has not been evaluated.

METHODS

We compared p-tau217, BD p-tau217, their amyloid beta 42 (Aβ42) ratios, BD p-tau217/p-tau217, and BD p-tau217/BD tau in end-of-life plasma from 288 neuropathologically characterized participants using a fully automated immunoassay. Biomarkers were assessed against National Institute on Aging-Alzheimer's Association (NIA-AA) classification, Thal phase, Braak stage, cognitive decline, and tau-PET (positron emission tomography).

RESULTS

All markers tracked neuropathological severity, with BD p-tau217 having larger fold-changes than p-tau217 but BD p-tau217/Aβ42 enhancing this further. BD p-tau217/BD tau achieved the highest area under the curve (AUC) for distinguishing Intermediate/High from Not/Low AD neuropathological change (ADNC) (0.89 vs 0.82 for p-tau217). Although BD p-tau217/p-tau217 showed smaller fold-changes, it had the strongest association with continuous tangle burden in AD (R2 = 0.68) and best predicted Clinical Dementia Rating Sum of Boxes (CDR-SB decline) (R2 = 0.26).

DISCUSSION: BD p-tau217 and BD-based ratios enhance dynamic range and prognostic performance while maintaining diagnostic accuracy, supporting further clinical evaluation.

Для цитирования: Denkinger Marisa N, Brum Wagner S, Leuzy Antoine, Singh Alpana, Marques Taina M, Ghisays Valentina, Protas Hillary, Su Yi, Atri Ali, Beach Thomas G, Serrano Geidy E, Bhatt Kinal, Carlson Corey M, Hoffmann Katharine, Reiman Eric M, Ashton Nicholas J. Brain-derived plasma p-tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2026. DOI: 10.1002/alz.71773.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.